TSDCA Seizes Ayurvedic Medicines for Misleading Claims, Violating Drugs and Magic Remedies Act

Jan 23, 2025

Share:

The Telangana State Drug Control Administration (TSDCA) has confiscated stocks of two Ayurvedic medicines, Rheuam Liniment and Stolist Capsules, for making misleading claims that violate the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

Key Highlights:
Seized Medicines:

  • Rheuam Liniment: Claimed to treat rheumatism; manufactured by Maheshwari Pharmaceuticals, Haridwar, Uttarakhand. Detected in Asifabad.

  • Stolist Capsules: Marketed to treat urinary stones; manufactured by Bhrigu’s Pharma, Haryana. Found in Medchal-Malkajgiri district.

Violation:

  • Both products carried misleading claims on their labels, contravening the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

  • The Act prohibits advertisements of drugs claiming to treat specific diseases or disorders without valid evidence.

Legal Action:
Misleading advertisements related to such drugs are punishable offenses under the Act.

Public Awareness Initiative:
The TSDCA has urged the public to report suspicious manufacturing or illegal activities related to drugs, including narcotics, psychotropic substances, or misleading advertisements.

Statements from Officials:
TSDCA officials emphasized the importance of regulatory compliance, stating, “Such misleading claims endanger public health and undermine consumer trust in Ayurveda-based products. The administration will continue its strict vigilance against such activities.”The TSDCA’s proactive action reflects its commitment to curbing false claims and ensuring the safety and efficacy of medical products. Public cooperation is vital to identifying and reporting similar violations.

misleading drug claims
ayurvedic medicine regulation
illegal medicines
Drugs and Magic Remedies Act
misleading drug claims
ayurvedic medicine regulation
illegal medicines
Drugs and Magic Remedies Act

TSDCA Seizes Ayurvedic Medicines for Misleading Claims, Violating Drugs and Magic Remedies Act

Jan 23, 2025

The Telangana State Drug Control Administration (TSDCA) has confiscated stocks of two Ayurvedic medicines, Rheuam Liniment and Stolist Capsules, for making misleading claims that violate the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

Key Highlights:
Seized Medicines:

  • Rheuam Liniment: Claimed to treat rheumatism; manufactured by Maheshwari Pharmaceuticals, Haridwar, Uttarakhand. Detected in Asifabad.

  • Stolist Capsules: Marketed to treat urinary stones; manufactured by Bhrigu’s Pharma, Haryana. Found in Medchal-Malkajgiri district.

Violation:

  • Both products carried misleading claims on their labels, contravening the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

  • The Act prohibits advertisements of drugs claiming to treat specific diseases or disorders without valid evidence.

Legal Action:
Misleading advertisements related to such drugs are punishable offenses under the Act.

Public Awareness Initiative:
The TSDCA has urged the public to report suspicious manufacturing or illegal activities related to drugs, including narcotics, psychotropic substances, or misleading advertisements.

Statements from Officials:
TSDCA officials emphasized the importance of regulatory compliance, stating, “Such misleading claims endanger public health and undermine consumer trust in Ayurveda-based products. The administration will continue its strict vigilance against such activities.”The TSDCA’s proactive action reflects its commitment to curbing false claims and ensuring the safety and efficacy of medical products. Public cooperation is vital to identifying and reporting similar violations.

Share:

misleading drug claims
ayurvedic medicine regulation
illegal medicines
Drugs and Magic Remedies Act
misleading drug claims
ayurvedic medicine regulation
illegal medicines
Drugs and Magic Remedies Act